Regent Investment Management LLC Ani Pharmaceuticals Inc Transaction History

Regent Investment Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 20, 2021	SELL	$28.4 - $36.14 $575,952 - $732,919	-20,280 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$23.69 - $31.47 $395,599 - $525,517	-16,699 Reduced 45.16%	20,280 $589,000
Q3 2020 Oct 19, 2020	SELL	$26.38 - $33.1 $68,588 - $86,060	-2,600 Reduced 6.57%	36,979 $1.04 Million
Q2 2020 Jul 29, 2020	SELL	$29.93 - $50.1 $29,930 - $50,100	-1,000 Reduced 2.46%	39,579 $1.28 Million
Q1 2020 Apr 17, 2020	SELL	$30.35 - $67.14 $22,762 - $50,355	-750 Reduced 1.81%	40,579 $1.65 Million
Q4 2019 Jan 30, 2020	BUY	$55.65 - $79.83 $92,935 - $133,316	1,670 Added 4.21%	41,329 $2.55 Million
Q3 2019 Oct 17, 2019	BUY	$64.7 - $85.39 $42,055 - $55,503	650 Added 1.67%	39,659 $2.89 Million
Q2 2019 Jul 15, 2019	SELL	$67.77 - $82.2 $273,113 - $331,266	-4,030 Reduced 9.36%	39,009 $3.21 Million
Q1 2019 Apr 22, 2019	SELL	$45.83 - $70.54 $197,069 - $303,322	-4,300 Reduced 9.08%	43,039 $3.04 Million
Q4 2018 Jan 22, 2019	BUY	$41.17 - $56.44 $37,053 - $50,796	900 Added 1.94%	47,339 $2.13 Million
Q3 2018 Oct 22, 2018	BUY	$52.95 - $71.34 $353,441 - $476,194	6,675 Added 16.79%	46,439 $2.63 Million
Q2 2018 Jul 16, 2018	BUY	$56.38 - $68.08 $214,187 - $258,635	3,799 Added 10.56%	39,764 $2.66 Million
Q1 2018 Apr 24, 2018	BUY	$56.98 - $72.41 $168,945 - $214,695	2,965 Added 8.98%	35,965 $2.09 Million
Q4 2017 Jan 26, 2018	BUY	$53.3 - $74.56 $295,815 - $413,808	5,550 Added 20.22%	33,000 $2.13 Million
Q3 2017 Oct 12, 2017	BUY	$43.46 - $52.49 $1.19 Million - $1.44 Million	27,450	27,450 $1.44 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $973M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Investment Management LLC with notifications on news.